APO Research
Talk to an analyst

APO RESEARCH · REPORT

Charcot-Marie-Tooth Disease Type I A Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Charcot-Marie-Tooth Disease Type I A Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025181 pages

Choose your research edition.

Industry ResearchCharcot-Marie-Tooth Disease Type I A Drug Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Charcot-Marie-Tooth Disease Type I A Drug Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Charcot-Marie-Tooth Disease Type I A Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Charcot-Marie-Tooth Disease Type I A Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Charcot-Marie-Tooth Disease Type I A Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Charcot-Marie-Tooth Disease Type I A Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Charcot-Marie-Tooth Disease Type I A Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Charcot-Marie-Tooth Disease Type I A Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Charcot-Marie-Tooth Disease Type I A Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Charcot-Marie-Tooth Disease Type I A Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Charcot-Marie-Tooth Disease Type I A Drug include Pharnext SA, Lead Discovery Center GmbH, Genzyme Corp, Affectis Pharmaceuticals AG and Addex Therapeutics Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Charcot-Marie-Tooth Disease Type I A Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Charcot-Marie-Tooth Disease Type I A Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Charcot-Marie-Tooth Disease Type I A Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Charcot-Marie-Tooth Disease Type I A Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Charcot-Marie-Tooth Disease Type I A Drug Segment by Company

Pharnext SA

Lead Discovery Center GmbH

Genzyme Corp

Affectis Pharmaceuticals AG

Addex Therapeutics Ltd

Charcot-Marie-Tooth Disease Type I A Drug Segment by Type

ADX-71441

AFC-5128

Others

Charcot-Marie-Tooth Disease Type I A Drug Segment by Application

Hospital

Clinic

Others

Charcot-Marie-Tooth Disease Type I A Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Charcot-Marie-Tooth Disease Type I A Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Charcot-Marie-Tooth Disease Type I A Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Charcot-Marie-Tooth Disease Type I A Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Charcot-Marie-Tooth Disease Type I A Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Charcot-Marie-Tooth Disease Type I A Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Charcot-Marie-Tooth Disease Type I A Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Charcot-Marie-Tooth Disease Type I A Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Charcot-Marie-Tooth Disease Type I A Drug Industry Trends Table 2. Charcot-Marie-Tooth Disease Type I A Drug Industry Drivers Table 3. Charcot-Marie-Tooth Disease Type I A Drug Industry Opportunities and Challenges Table 4. Charcot-Marie-Tooth Disease Type I A Drug Industry Restraints Table 5. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Manufacturers Table 9. Global Charcot-Marie-Tooth Disease Type I A Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Charcot-Marie-Tooth Disease Type I A Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Charcot-Marie-Tooth Disease Type I A Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Charcot-Marie-Tooth Disease Type I A Drug Manufacturers, Product Type & Application Table 13. Global Charcot-Marie-Tooth Disease Type I A Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Charcot-Marie-Tooth Disease Type I A Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of ADX-71441 Table 17. Major Manufacturers of AFC-5128 Table 18. Major Manufacturers of Others Table 19. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2026) & (K Units) Table 21. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2027-2032) & (K Units) Table 22. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Type (2021-2026) Table 23. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Type (2027-2032) Table 24. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021-2026) & (K Units) Table 26. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2027-2032) & (K Units) Table 27. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Type (2021-2026) Table 28. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Others Table 32. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2026) & (K Units) Table 34. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2027-2032) & (K Units) Table 35. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Application (2021-2026) Table 36. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Application (2027-2032) Table 37. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021-2026) & (K Units) Table 39. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2027-2032) & (K Units) Table 40. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Application (2021-2026) Table 41. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Application (2027-2032) Table 42. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Region (2021-2026) Table 45. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Charcot-Marie-Tooth Disease Type I A Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2026) & (K Units) Table 49. North America Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2027-2032) & (K Units) Table 50. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2026) & (K Units) Table 52. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Charcot-Marie-Tooth Disease Type I A Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Charcot-Marie-Tooth Disease Type I A Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2027-2032) & (K Units) Table 59. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Region (2021-2026) Table 63. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Region (2027-2032) Table 64. Pharnext SA Company Information Table 65. Pharnext SA Business Overview Table 66. Pharnext SA Charcot-Marie-Tooth Disease Type I A Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Pharnext SA Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio Table 68. Pharnext SA Recent Development Table 69. Lead Discovery Center GmbH Company Information Table 70. Lead Discovery Center GmbH Business Overview Table 71. Lead Discovery Center GmbH Charcot-Marie-Tooth Disease Type I A Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Lead Discovery Center GmbH Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio Table 73. Lead Discovery Center GmbH Recent Development Table 74. Genzyme Corp Company Information Table 75. Genzyme Corp Business Overview Table 76. Genzyme Corp Charcot-Marie-Tooth Disease Type I A Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Genzyme Corp Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio Table 78. Genzyme Corp Recent Development Table 79. Affectis Pharmaceuticals AG Company Information Table 80. Affectis Pharmaceuticals AG Business Overview Table 81. Affectis Pharmaceuticals AG Charcot-Marie-Tooth Disease Type I A Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Affectis Pharmaceuticals AG Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio Table 83. Affectis Pharmaceuticals AG Recent Development Table 84. Addex Therapeutics Ltd Company Information Table 85. Addex Therapeutics Ltd Business Overview Table 86. Addex Therapeutics Ltd Charcot-Marie-Tooth Disease Type I A Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Addex Therapeutics Ltd Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio Table 88. Addex Therapeutics Ltd Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Charcot-Marie-Tooth Disease Type I A Drug Distributors List Table 92. Charcot-Marie-Tooth Disease Type I A Drug Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Charcot-Marie-Tooth Disease Type I A Drug Product Image Figure 2. Global Charcot-Marie-Tooth Disease Type I A Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Charcot-Marie-Tooth Disease Type I A Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Charcot-Marie-Tooth Disease Type I A Drug Sales (2021-2032) & (K Units) Figure 5. Global Charcot-Marie-Tooth Disease Type I A Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Charcot-Marie-Tooth Disease Type I A Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. ADX-71441 Image Figure 9. AFC-5128 Image Figure 10. Others Image Figure 11. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Type (2021-2032) Figure 14. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Application (2021-2032) Figure 23. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Application (2021-2032) Figure 26. North America Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Country (2021-2032) Figure 28. U.S. Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Country (2021-2032) Figure 33. Germany Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Country (2021-2032) Figure 40. China Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Country (2021-2032) Figure 48. Brazil Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Charcot-Marie-Tooth Disease Type I A Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Figure 59. North America Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Figure 61. Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Charcot-Marie-Tooth Disease Type I A Drug Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Charcot-Marie-Tooth Disease Type I A Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • ADX-71441
  • AFC-5128
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Pharnext SA
  • Lead Discovery Center GmbH
  • Genzyme Corp
  • Affectis Pharmaceuticals AG
  • Addex Therapeutics Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Charcot-Marie-Tooth Disease Type I A Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Charcot-Marie-Tooth Disease Type I A Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Charcot-Marie-Tooth Disease Type I A Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Charcot-Marie-Tooth Disease Type I A Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Charcot-Marie-Tooth Disease Type I A Drug Market Dynamics
  1. 2.1 Charcot-Marie-Tooth Disease Type I A Drug Industry Trends
  2. 2.2 Charcot-Marie-Tooth Disease Type I A Drug Industry Drivers
  3. 2.3 Charcot-Marie-Tooth Disease Type I A Drug Industry Opportunities and Challenges
  4. 2.4 Charcot-Marie-Tooth Disease Type I A Drug Industry Restraints
3 Charcot-Marie-Tooth Disease Type I A Drug Market by Manufacturers
  1. 3.1 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Charcot-Marie-Tooth Disease Type I A Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Charcot-Marie-Tooth Disease Type I A Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Charcot-Marie-Tooth Disease Type I A Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Charcot-Marie-Tooth Disease Type I A Drug Manufacturers, Product Type & Application
  7. 3.7 Global Charcot-Marie-Tooth Disease Type I A Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Charcot-Marie-Tooth Disease Type I A Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Charcot-Marie-Tooth Disease Type I A Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Charcot-Marie-Tooth Disease Type I A Drug Tier 1, Tier 2, and Tier 3
4 Charcot-Marie-Tooth Disease Type I A Drug Market by Type
  1. 4.1 Charcot-Marie-Tooth Disease Type I A Drug Type Introduction
  2. 4.1.1 ADX-71441
  3. 4.1.2 AFC-5128
  4. 4.1.3 Others
  5. 4.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type
  6. 4.2.1 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2032)
  8. 4.2.3 Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Type (2021-2032)
  9. 4.3 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type
  10. 4.3.1 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021-2032)
  12. 4.3.3 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Type (2021-2032)
5 Charcot-Marie-Tooth Disease Type I A Drug Market by Application
  1. 5.1 Charcot-Marie-Tooth Disease Type I A Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application
  6. 5.2.1 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application
  10. 5.3.1 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Application (2021-2032)
6 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Region
  1. 6.1 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Charcot-Marie-Tooth Disease Type I A Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Charcot-Marie-Tooth Disease Type I A Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Charcot-Marie-Tooth Disease Type I A Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Charcot-Marie-Tooth Disease Type I A Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Region
  1. 7.1 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Region
  2. 7.1.1 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032)
  8. 7.2.2 North America Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032)
  11. 7.3.2 Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Pharnext SA
  2. 8.1.1 Pharnext SA Company Information
  3. 8.1.2 Pharnext SA Business Overview
  4. 8.1.3 Pharnext SA Charcot-Marie-Tooth Disease Type I A Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pharnext SA Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio
  6. 8.1.5 Pharnext SA Recent Developments
  7. 8.2 Lead Discovery Center GmbH
  8. 8.2.1 Lead Discovery Center GmbH Company Information
  9. 8.2.2 Lead Discovery Center GmbH Business Overview
  10. 8.2.3 Lead Discovery Center GmbH Charcot-Marie-Tooth Disease Type I A Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lead Discovery Center GmbH Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio
  12. 8.2.5 Lead Discovery Center GmbH Recent Developments
  13. 8.3 Genzyme Corp
  14. 8.3.1 Genzyme Corp Company Information
  15. 8.3.2 Genzyme Corp Business Overview
  16. 8.3.3 Genzyme Corp Charcot-Marie-Tooth Disease Type I A Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Genzyme Corp Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio
  18. 8.3.5 Genzyme Corp Recent Developments
  19. 8.4 Affectis Pharmaceuticals AG
  20. 8.4.1 Affectis Pharmaceuticals AG Company Information
  21. 8.4.2 Affectis Pharmaceuticals AG Business Overview
  22. 8.4.3 Affectis Pharmaceuticals AG Charcot-Marie-Tooth Disease Type I A Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Affectis Pharmaceuticals AG Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio
  24. 8.4.5 Affectis Pharmaceuticals AG Recent Developments
  25. 8.5 Addex Therapeutics Ltd
  26. 8.5.1 Addex Therapeutics Ltd Company Information
  27. 8.5.2 Addex Therapeutics Ltd Business Overview
  28. 8.5.3 Addex Therapeutics Ltd Charcot-Marie-Tooth Disease Type I A Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Addex Therapeutics Ltd Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio
  30. 8.5.5 Addex Therapeutics Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Charcot-Marie-Tooth Disease Type I A Drug Value Chain Analysis
  2. 9.1.1 Charcot-Marie-Tooth Disease Type I A Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Charcot-Marie-Tooth Disease Type I A Drug Production Mode & Process
  6. 9.2 Charcot-Marie-Tooth Disease Type I A Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Charcot-Marie-Tooth Disease Type I A Drug Distributors
  9. 9.2.3 Charcot-Marie-Tooth Disease Type I A Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst